Augustine Asset Management Inc Biogen Inc. Transaction History

Augustine Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 Apr 11, 2019	SELL	$216.71 - $338.96 $1.86 Million - $2.9 Million	-8,563 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$278.5 - $352.75 $131,173 - $166,145	-471 Reduced 5.21%	8,563 $2.58 Million
Q3 2018 Oct 23, 2018	SELL	$293.51 - $383.83 $179,041 - $234,136	-610 Reduced 6.33%	9,034 $3.19 Million
Q2 2018 Jul 12, 2018	SELL	$257.52 - $306.91 $5,407 - $6,445	-21 Reduced 0.22%	9,644 $0
Q1 2018 May 01, 2018	BUY	$260.13 - $367.91 $50,465 - $71,374	194 Added 2.05%	9,665 $2.65 Million
Q4 2017 Jan 22, 2018	BUY	$307.64 - $344.58 $2.91 Million - $3.26 Million	9,471	9,471 $3.02 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Augustine Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Augustine Asset Management Inc with notifications on news.